Navigation Links
John Mendelsohn M.D, chosen for an International Award

The president of The University of Texas, M. D. Anderson Cancer Center, John Mendelsohn, has been chosen as a co-recipient of a 2006 Dan David Prize// . This announcement was made in Paris, for his path breaking research in Cancer Therapy.

The Dan David Foundation which is located at the Tel Aviv University distributed these annual awards which consist of three prizes of $1 million each to laureates chosen in areas where the contribution is immense and path breaking. "It is a tremendous honor to be awarded the Dan David Prize," Mendelsohn says. "It's especially gratifying to be honored for research that has played a role in the future care of patients with cancer. I am pleased to share this award with Dr. Schlessinger whom I have known for many years as a pioneer in the field of growth factor signaling. We have published one research article together."

This 2006, “Future Dimension Award” focuses on Cancer Therapy and according to the foundation, Mendelson was awarded the prize for “pioneering the rapidly developing field of antibody-mediated cancer therapy in general and that of antibodies to growth factors in particular”. Nearly two decades have seen Mendelson steeped in research on how growth factors impact the multiplication of cancer cells.

Mendelssohn’s strengths are clinical and laboratory research and has also steered M. D. Anderson in its administration, over the last ten years. M. D. Anderson has to its credit, the acclaim of being named the top cancer hospital in the nation four years in succession in the last five years, as per the "America's Best Hospitals" survey.
'"/>




Page: 1

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. Thailand To Procure Botulism Antitoxin Internationally
11. International Rating System To Be Introduced For Hospitals In India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... New York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are ... every 3 kids do not brush their teeth the minimum two times a day that ... teeth; with students missing 51 million hours of school and adults missing 164 million hours ...
(Date:3/23/2017)... Los Angeles, CA (PRWEB) , ... March 23, ... ... Series A funding investment in Los Angeles based healthcare technology company California Healthcom ... group’s portfolio into the US, and healthcare arena. With headquarters in California, CHG ...
(Date:3/23/2017)... ... 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from nearly ... in crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle ... , “We’re excited to be operating on U.S. shores, where most of our initial ...
(Date:3/23/2017)... ... 23, 2017 , ... According to the National Sleep Foundation , poor ... the only cause of the sunken-eye look, which can include dark circles or bags ... poor health are likely due to genetics, dehydration, allergies, and losing fat beneath the ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance ... Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , ... only to the association, but also to the Health Care Quality and Patient Safety ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, 2017 /PRNewswire/ ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company developing ... announced that data from its successful Phase 2a study ... treatment for localized prostate cancer, will be presented as ... nd Annual European Association of Urology in ...
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... LITTLE SILVER, N.J. , March 23, 2017 ... device company, today announced that it has kicked ... in-growth into their 3D printed bone segments. ... of Engineering, "Our unique variable honeycomb lattice structures ... bone in-growth as compared to current allograft wedges ...
Breaking Medicine Technology: